Unknown

Dataset Information

0

One-year Mortality Outcomes From the Advancing Cryptococcal Meningitis Treatment for Africa Trial of Cryptococcal Meningitis Treatment in Malawi.


ABSTRACT: In Malawi, 236 participants from the Advancing Cryptococcal Meningitis Treatment for Africa trial were followed for 12 months. The trial outcomes reported at 10 weeks were sustained to 1 year. One-week amphotericin B plus flucytosine was associated with the lowest 1 year mortality (27.5% [95% confidence interval, 16.3 to 44.1]).

SUBMITTER: Kanyama C 

PROVIDER: S-EPMC7105249 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6669289 | biostudies-literature
| S-EPMC8162582 | biostudies-literature
| S-EPMC4222805 | biostudies-literature
| S-EPMC8257409 | biostudies-literature
| S-EPMC7384323 | biostudies-literature
| S-EPMC8501291 | biostudies-literature
| S-EPMC6105915 | biostudies-literature
| S-EPMC6907845 | biostudies-literature
| S-EPMC3966372 | biostudies-literature
| S-EPMC6107745 | biostudies-literature